Economic burden of toxicities associated with treating metastatic melanoma in eight countries

BACKGROUND: Information on costs of managing adverse events (AEs) associated with current treatments in metastatic melanoma is limited. This study estimates costs of AEs in eight countries: Australia (AU), Canada (CA), France (FR), Germany (GE), Italy (IT), the Netherlands (NL), Spain (ES), and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehler, Elizabeth, Zhao, Zhongyun, Pinar Bilir, S., Munakata, Julie, Barber, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209401/
https://www.ncbi.nlm.nih.gov/pubmed/26721505
http://dx.doi.org/10.1007/s10198-015-0757-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209401/
https://www.ncbi.nlm.nih.gov/pubmed/26721505
http://dx.doi.org/10.1007/s10198-015-0757-y

Ejemplares similares